Comparison between Bafna Pharmaceuticals IPO and Niraj Cement Structurals IPO.
Bafna Pharmaceuticals IPO is a Mainboard Bookbuilding IPO proposed to list at BSE while Niraj Cement Structurals IPO is a Mainboard Bookbuilding proposed to list at BSE.
The total issue size of Bafna Pharmaceuticals IPO is up to ₹25.60 Cr whereas the issue size of the Niraj Cement Structurals IPO is up to ₹61.75 Cr. The final issue price of Bafna Pharmaceuticals IPO is ₹40.00 per share and of Niraj Cement Structurals IPO is ₹190.00 per share.
| Bafna Pharmaceuticals IPO | Niraj Cement Structurals IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹175.00 per share | |
| Issue Price (Upper) | ₹190.00 per share | |
| Issue Price (Final) | ₹40.00 per share | ₹190.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ₹0.00 per share | |
| Market Lot Size | 30 shares | |
| Fresh Issue Size | 64,00,206 shares | 32,50,000 shares |
| Fresh Issue Size (Amount) | up to ₹25.60 Cr | up to ₹61.75 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 64,00,206 shares | 32,50,000 shares |
| Issue Size Total (Amount) | up to ₹25.60 Cr | up to ₹61.75 Cr |
Bafna Pharmaceuticals IPO opens on May 27, 2008, while Niraj Cement Structurals IPO opens on May 26, 2008. The closing date of Bafna Pharmaceuticals IPO and Niraj Cement Structurals IPO is May 30, 2008, and May 30, 2008, respectively.
| Bafna Pharmaceuticals IPO | Niraj Cement Structurals IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | May 27, 2008 | May 26, 2008 |
| Issue Close | May 30, 2008 | May 30, 2008 |
| Basis Of Allotment (Tentative) | ||
| Initiation of Refunds (Tentative) | ||
| Credit of Share (Tentative) | ||
| Listing date (Tentative) | Jun 27, 2008 | Jun 19, 2008 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Bafna Pharmaceuticals IPO P/E ratio is , as compared to Niraj Cement Structurals IPO P/E ratio of .
| Bafna Pharmaceuticals IPO | Niraj Cement Structurals IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | 71.07 | 100 | ||||
| Promoter Shareholding (Post-Issue) | 42.6 | 68.58 | ||||
| P/E Ratio | ||||||
| Market Cap | ₹63.92 Cr. | ₹196.51 Cr. | ||||
| ROE | ||||||
| ROCE | ||||||
| Debt/Equity | ||||||
| EPS | ||||||
| RoNW | 10.65 | 12.87 |
In the Bafna Pharmaceuticals IPO Retail Individual Investors (RII) are offered 32,00,000 shares while in Niraj Cement Structurals IPO retail investors are offered 32,00,000 shares. Qualified Institutional Buyers (QIB) are offered in Bafna Pharmaceuticals IPO and 14,62,500 shares in Niraj Cement Structurals IPO.
| Bafna Pharmaceuticals IPO | Niraj Cement Structurals IPO | |
|---|---|---|
| Anchor Investor Reservation | ||
| Market Maker Reservation | ||
| QIB | 14,62,500 shares | |
| NII | 32,00,000 shares | 4,38,750 shares |
| RII | 32,00,000 shares | 10,23,750 shares |
| Employee | 3,25,000 shares | |
| Others | ||
| Total | 64,00,000 shares | 32,50,000 shares |
Bafna Pharmaceuticals IPO subscribed 4.88x in total, whereas Niraj Cement Structurals IPO subscribed 1.74x.
| Bafna Pharmaceuticals IPO | Niraj Cement Structurals IPO | |
|---|---|---|
| QIB (times) | 0.00x | |
| NII (times) | 1.57x | 4.01x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 8.20x | 3.81x |
| Employee (times) | 0.00x | |
| Other (times) | ||
| Total (times) | 4.88x | 1.74x |
